Literature DB >> 8603005

Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia.

S Mould1, A Gardiner, M Corcoran, D G Oscier.   

Abstract

Trisomy 12 and deletions or translocations of 13q14 are the commonest cytogenetic abnormalities in chronic lymphocytic leukaemia but rarely co-exist in the same patient. We describe eight patients from a series of > 400 patients with CLL in whom trisomy 12 and t or del 13 occur in the same clone. Using FISH we have identified clones with trisomy 12 alone, t or del 13q14 alone and both abnormalities, in each of the patients studied. This implies that neither trisomy 12 nor t or del 13q14 is the initiating event in leukaemogenesis, but does not exclude the possibility of a submicroscopic abnormality of 13q14 occurring as an early event.

Entities:  

Mesh:

Year:  1996        PMID: 8603005     DOI: 10.1046/j.1365-2141.1996.d01-1492.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.

Authors:  Wei Xu; Jian-Yong Li; Jin-Lan Pan; Hai-Rong Qiu; Yun-Feng Shen; Li Li; Ya-Fang Wu; Yong-Quan Xue
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

2.  Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).

Authors:  Sílvia Beà; Armando López-Guillermo; Maria Ribas; Xavier Puig; Magda Pinyol; Ana Carrió; Lurdes Zamora; Francesc Soler; Francesc Bosch; Stephan Stilgenbauer; Dolors Colomer; Rosa Miró; Emili Montserrat; Elias Campo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

3.  Genomic instability in a chronic lymphocytic leukemia patient with mono-allelic deletion of the DLEU and RB1 genes.

Authors:  María Paulina Nava-Rodríguez; Martín Daniel Domínguez-Cruz; Lilia Beatriz Aguilar-López; César Borjas-Gutiérrez; María Teresa Magaña-Torres; Juan Ramón González-García
Journal:  Mol Cytogenet       Date:  2019-01-31       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.